Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (4553)	6/24/1998 11:27:00 PM
From: Pseudo Biologist	Read Replies (2) of 6136

Peter, I think Rick is looking ahead to IMNR's Remune, and (from their web page): REMUNE is composed of gp120-depleted HIV-1 propagated in HUT-78 cells and inactivated in beta-propriolactone and irradiation. REMUNE is derived from Zairian HIV-1 strain HZ-321. The inactivated material is emulsified with mineral oil (Incomplete Freund's Adjuvant) in the final formulation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next